2015
DOI: 10.1016/j.lfs.2014.11.028
|View full text |Cite
|
Sign up to set email alerts
|

Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 67 publications
0
11
0
2
Order By: Relevance
“…The development of the tumor was higher in obese-MSG tumor rats compared to control tumor rats. Activation of the insulin-IR-ERK1/2 pathway and an anti-apoptotic effect might be the mechanisms involved in the higher development of tumors in obesity (de Queiroz, Akamine, de Carvalho, Sampaio, & Fortes, 2015;Fonseca et al, 2011).…”
Section: Promotion Of Tumor Development In Msg-induced Obesitymentioning
confidence: 99%
“…The development of the tumor was higher in obese-MSG tumor rats compared to control tumor rats. Activation of the insulin-IR-ERK1/2 pathway and an anti-apoptotic effect might be the mechanisms involved in the higher development of tumors in obesity (de Queiroz, Akamine, de Carvalho, Sampaio, & Fortes, 2015;Fonseca et al, 2011).…”
Section: Promotion Of Tumor Development In Msg-induced Obesitymentioning
confidence: 99%
“…To date, many drugs associated with obesity such as lipid-lowering (statins) or antidiabetic drugs (metformin) have been used in cancer treatment with good effects (Brown, 2007;De Queiroz et al, 2015;Hager et al, 2006;Hanai et al, 2012;Wang et al, 2014). Appropriately, it has been demonstrated that both statins and metformin are able to increase the activity of FOXO3 (De Queiroz et al, 2015;Wolfe et al, 2015), whereas metformin is also able to inhibit the expression of FOXM1 . Collectively, these observations advocate further that targeting lipid metabolism in conjunction with the FOXO3-FOXM1 axis maybe a viable strategy for tackling cancer development, progression and drug resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Yang et al (2006) showed that the fermentation broth containing a mixture of polysaccharides derived from Antrodia camphorate, as well as other chemicals, induced cell-death in a dose-and time-dependent manner in MCF-7 cells, and that this effect was associated with an increase in apoptosis and ROS generation. In another study, Weng et al (2011) The LKB1/AMPK pathway (serine/threonine kinase LKB1 (Liver Kinase B1), a tumor suppressor and key upstream activator of AMPK through direct phosphorylation, Shackelford and Shaw 2009) serves as a metabolic checkpoint in the cell, and has been described as an important pathway in the inhibition of cellular growth and promotion of apoptosis in cancer cells by inhibiting mTOR and p70S6K activities, as well as by activating p53 protein (Berstein et al, 2010;Feng et al, 2007;Queiroz et al, 2014;Queiroz et al, 2015;Zakikhani et al, 2008). In addition, studies have shown that AMPK can activate the Forkhead transcription factor, FOXO proteins, in conditions such as nutrient deprivation thereby increasing cell survival (Chiacchiera et al, 2009;Greer et al, 2009).…”
Section: Discussionmentioning
confidence: 99%